TrialJournal of the Pediatric Infectious Diseases Society2020

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

Rolando M Viani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.